Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain
Authors
Keywords
-
Journal
Cells
Volume 12, Issue 9, Pages 1275
Publisher
MDPI AG
Online
2023-04-28
DOI
10.3390/cells12091275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endocannabinoid and Prostanoid Crosstalk in Pain
- (2019) Baptiste Buisseret et al. TRENDS IN MOLECULAR MEDICINE
- Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain
- (2018) Amanda J. Morgan et al. ACS Chemical Neuroscience
- WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms
- (2018) Jie Wen et al. Journal of Neuroinflammation
- Enhanced endocannabinoid tone as a potential target of pharmacotherapy
- (2018) Marek Toczek et al. LIFE SCIENCES
- Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury
- (2018) Melissa Jones et al. Frontiers in Pharmacology
- The cannabinoid system and pain
- (2017) Stephen G. Woodhams et al. NEUROPHARMACOLOGY
- The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
- (2017) Giulia Donvito et al. NEUROPSYCHOPHARMACOLOGY
- Structure–activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009–2016)
- (2017) G. Carullo et al. MedChemComm
- Interleukin-6: an emerging regulator of pathological pain
- (2016) Ya-Qun Zhou et al. Journal of Neuroinflammation
- Pain regulation by non-neuronal cells and inflammation
- (2016) R.-R. Ji et al. SCIENCE
- Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
- (2016) Joyonna Carrie Gamble-George et al. eLife
- Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems—A Novel Treatment Option for Chronic Pain Management
- (2016) Natalia Malek et al. Frontiers in Pharmacology
- ADouble Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation
- (2015) Rita Scarpelli et al. ChemMedChem
- R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
- (2014) K. Schmitz et al. EMBO Molecular Medicine
- Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models
- (2014) Travis W. Grim et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
- (2014) Daniel J. Hermanson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Importance of glial activation in neuropathic pain
- (2013) Joanna Mika et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
- (2013) Daniel J Hermanson et al. NATURE NEUROSCIENCE
- Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all
- (2012) Vincenzo Di Marzo PAIN
- An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
- (2012) John P. Huggins et al. PAIN
- Discovery of Prostamide F2α and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability
- (2012) Luisa Gatta et al. PLoS One
- The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
- (2011) J. R. Savinainen et al. Acta Physiologica
- Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
- (2011) Carol A. Rouzer et al. CHEMICAL REVIEWS
- Peripheral Nerve Injury Alters Blood-Spinal Cord Barrier Functional and Molecular Integrity through a Selective Inflammatory Pathway
- (2011) S. Echeverry et al. JOURNAL OF NEUROSCIENCE
- Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
- (2011) K. Ahn et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
- (2011) Kelsey C Duggan et al. Nature Chemical Biology
- Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol
- (2010) Natsuo Ueda et al. BIOFACTORS
- Chemokines, neuronal–glial interactions, and central processing of neuropathic pain
- (2010) Yong-Jing Gao et al. PHARMACOLOGY & THERAPEUTICS
- R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
- (2010) Philipp Bishay et al. PLoS One
- The Role of Glia and the Immune System in the Development and Maintenance of Neuropathic Pain
- (2010) Ricardo Vallejo et al. Pain Practice
- Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice
- (2009) Joel E. Schlosburg et al. AAPS Journal
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Substance P Drives Endocannabinoid-Mediated Disinhibition in a Midbrain Descending Analgesic Pathway
- (2009) G. M. Drew et al. JOURNAL OF NEUROSCIENCE
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality
- (2009) Jeannie Hwang et al. LIFE SCIENCES
- Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia
- (2009) Devi Rani Sagar et al. Molecular Pain
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started